Histogenics successfully completed consultations with Japan’s PMDA regarding the regulatory path for NeoCart® autologous cell therapy for the treatment of knee cartilage...
TheraCell was issued U.S. Patent No. 9,636,436, "Compositions of and Methods for Cancellous Bone Matrix," addressing its ECS™ enhanced cancellous demineralized...
SpinalCyte was issued Australian Patent No. 2013299505, “Generation of Cartilage Ex Vivo from Fibroblasts.”...
CellRight Technologies launched Matrix OI® Cortical Fibers, the latest in vivo verified osteoinductive matrix in its portfolio of regenerative human-derived...
Orthocell received a new patent in Singapore titled "Method for Producing a Collagen Membrane and Uses Thereof," relative to the CelGro®...
Six-month results from Phase I/II study indicate that RepliCel’s RCT-01 fibroblasts demonstrated product safety and clinical potential for tendon regeneration...
Burst Biologics received IRB approval for a U.S. prospective clinical study of BioBurst cellular allograft in spinal fusion....
Study results indicate that Rotation Medical’s collagen-based Bioinductive Implant induced new tissue formation in all study participants with large and massive...
Studies suggest that a single injection of Mesenchymal Precursor Cells resulted in meaningful improvements in chronic low back pain and function...
SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.
0 
